Your browser doesn't support javascript.
loading
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
Oh, Do-Youn; Maqueda, Maria Alsina; Quinn, David I; O'Dwyer, Peter J; Chau, Ian; Kim, Sun Young; Duran, Ignacio; Castellano, Daniel; Berlin, Jordan; Mellado, Begona; Williamson, Stephen K; Lee, Keun-Wook; Marti, Francisca; Mathew, Paul; Saif, Muhammad Wasif; Wang, Ding; Chong, Elizabeth; Hilger-Rolfe, Jacqueline; Dean, James P; Arkenau, Hendrik-Tobias.
Afiliación
  • Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul National University Graduate School, Seoul, South Korea. ohdoyoun@snu.ac.kr.
  • Maqueda MA; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Quinn DI; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA.
  • O'Dwyer PJ; University of Pennsylvania, Philadelphia, PA, USA.
  • Chau I; The Royal Marsden NHS Foundation Trust-Royal Marsden Hospital, London, UK.
  • Kim SY; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.
  • Duran I; Hospital Universitario Marques de Valdecilla, IDIVAL, Santander, Spain.
  • Castellano D; Hospital Universitario, 12 de Octubre, Madrid, Spain.
  • Berlin J; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Mellado B; Medical Oncology Department, Hospital Clinic i Provincial de Barcelona, IDIBAPS, University of Barcelona, Barcelona, Spain.
  • Williamson SK; University of Kansas Hospital Cancer Center, Kansas City, KS, USA.
  • Lee KW; Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea.
  • Marti F; The Christie NHS Foundation Trust, Manchester, UK.
  • Mathew P; Tufts Medical Center, Boston, MA, USA.
  • Saif MW; Tufts Medical Center, Boston, MA, USA.
  • Wang D; Orlando Health Cancer Institute, Orlando, FL, USA.
  • Chong E; Henry Ford Hospital, Detroit, MI, USA.
  • Hilger-Rolfe J; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USA.
  • Dean JP; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USA.
  • Arkenau HT; Pharmacyclics LLC, an AbbVie Company, South San Francisco, CA, USA.
BMC Cancer ; 23(1): 1056, 2023 Nov 03.
Article en En | MEDLINE | ID: mdl-37919668
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Carcinoma de Células Renales / Neoplasias Renales Límite: Humans Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Corea del Sur